These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Fatty acid beta-oxidation deficiency masquerading as fulminant myocarditis. de Lonlay-Debeney P; Fournet JC; Bonnet D Int J Cardiol; 1998 Aug; 65(3):287-9. PubMed ID: 9740486 [TBL] [Abstract][Full Text] [Related]
46. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380 [No Abstract] [Full Text] [Related]
47. More on the Mennonites. Yoder V Kans Med; 1993 Feb; 94(2):53. PubMed ID: 8468905 [No Abstract] [Full Text] [Related]
48. [Hyperuricemia as the main symptom of medium-chain acyl-Co-A dehydrogenase deficiency]. Reinehr T; Bürk G; Dietz B; Schlüter B; Andler W Klin Padiatr; 1997; 209(6):357-60. PubMed ID: 9445919 [TBL] [Abstract][Full Text] [Related]
49. Genetic defects of acyl-CoA dehydrogenases: studies using an electron transfer flavoprotein reduction assay. Hale DE; Stanley CA; Coates PM Prog Clin Biol Res; 1990; 321():333-48. PubMed ID: 2326298 [No Abstract] [Full Text] [Related]
50. Tandem mass spectrometry in newborn screening. American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group. American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group Genet Med; 2000; 2(4):267-9. PubMed ID: 11252712 [No Abstract] [Full Text] [Related]
51. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment. Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663 [No Abstract] [Full Text] [Related]
52. The fate of orally ingested 3-phenylpropionic acid. Duran M; van Vossen R; Bruinvis L; Ketting D; Dorland L; de Klerk JB Prog Clin Biol Res; 1990; 321():419-26. PubMed ID: 2326303 [No Abstract] [Full Text] [Related]
53. The incidence and presentation of dicarboxylic aciduria. Bennett MJ; Worthy E; Pollitt RJ J Inherit Metab Dis; 1987; 10(3):241-2. PubMed ID: 3123781 [No Abstract] [Full Text] [Related]
54. The sudden infant death syndrome gene: does it exist? Opdal SH; Rognum TO Pediatrics; 2004 Oct; 114(4):e506-12. PubMed ID: 15466077 [TBL] [Abstract][Full Text] [Related]
55. Post-mortem analysis for two prevalent beta-oxidation mutations in sudden infant death. Yang Z; Lantz PE; Ibdah JA Pediatr Int; 2007 Dec; 49(6):883-7. PubMed ID: 18045290 [TBL] [Abstract][Full Text] [Related]
56. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death. Pollitt RJ Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423 [TBL] [Abstract][Full Text] [Related]
58. Methods for the investigation of hypoglycaemia with particular reference to inherited disorders of mitochondrial beta-oxidation. Bartlett K Baillieres Clin Endocrinol Metab; 1993 Jul; 7(3):643-67. PubMed ID: 8379909 [No Abstract] [Full Text] [Related]
59. MCAD deficiency in the Holderman Mennonite population in central Kansas. Casey JL Kans Med; 1992 Nov; 93(11):306-8. PubMed ID: 1460814 [No Abstract] [Full Text] [Related]
60. A genetic defect in carnitine transport causing primary carnitine deficiency. Stanley CA; Treem WR; Hale DE; Coates PM Prog Clin Biol Res; 1990; 321():457-64. PubMed ID: 2326306 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]